Amelioration of 4′-epidoxorubicin-induced cardiotoxicity by sodium cromoglycate
- 1 February 1989
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 25 (2), 361-368
- https://doi.org/10.1016/0277-5379(89)90031-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivoBritish Journal of Cancer, 1986
- Effect of polyethylene glycol 400 on adriamycin induced histamine releaseEuropean Journal of Cancer and Clinical Oncology, 1986
- Characterization of histamine secretion induced by anthracyclines in rat peritoneal mast cellsBiochemical Pharmacology, 1986
- Mediation of Subacute Anthracycline Cardiotoxicity in Rabbits by Cardiac Histamine ReleaseJournal of Cardiovascular Pharmacology, 1983
- Agents that Release Histamine from Mast CellsAnnual Review of Pharmacology and Toxicology, 1983
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- ANTHRACYCLINE-ASSOCIATED CARDIAC AND RENAL DAMAGE IN RABBITS - EVIDENCE FOR MEDIATION BY VASOACTIVE SUBSTANCES1981
- Acute and Chronic Cardiovascular Effects of Doxorubicin in the DogJournal of Cardiovascular Pharmacology, 1980
- The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 4880Life Sciences, 1971